Alessio Amatu

10.0k total citations · 1 hit paper
80 papers, 2.4k citations indexed

About

Alessio Amatu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Alessio Amatu has authored 80 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 36 papers in Pulmonary and Respiratory Medicine and 27 papers in Cancer Research. Recurrent topics in Alessio Amatu's work include Colorectal Cancer Treatments and Studies (40 papers), Cancer Genomics and Diagnostics (25 papers) and Lung Cancer Treatments and Mutations (17 papers). Alessio Amatu is often cited by papers focused on Colorectal Cancer Treatments and Studies (40 papers), Cancer Genomics and Diagnostics (25 papers) and Lung Cancer Treatments and Mutations (17 papers). Alessio Amatu collaborates with scholars based in Italy, Spain and United States. Alessio Amatu's co-authors include Salvatore Siena, Andrea Sartore‐Bianchi, Katia Bencardino, Federica Tosi, Elio Gregory Pizzutilo, Alberto Bardelli, Gianluca Mauri, Giulia Siravegna, Erica Bonazzina and Giorgio Patelli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Alessio Amatu

80 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

2016 424 citations Alessio Amatu, Andrea Sartore‐Bianchi et al. ESMO Open profile →

Peers

Alessio Amatu

ONCOL

PRM

PFM

Katia Bencardino Italy

Francesca Bergamo Italy

Simon Pernot France

In‐Gu Do South Korea

D. J. Richel Netherlands

Anne Cayre France

O. Kisker Germany

Yuan‐Tzu Lan Taiwan

Changping Wu China

Stephen Leong United States

Katia Bencardino Italy

Alessio Amatu

1.8k ×1.2

ONCOL

806 ×1.0

PRM

591 ×1.0

592 ×1.0

669 ×1.2

PFM

Citations per year, relative to Alessio Amatu Alessio Amatu (= 1×) peers Katia Bencardino

Countries citing papers authored by Alessio Amatu

Since Specialization

Citations

This map shows the geographic impact of Alessio Amatu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessio Amatu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessio Amatu more than expected).

Fields of papers citing papers by Alessio Amatu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessio Amatu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessio Amatu. The network helps show where Alessio Amatu may publish in the future.

Co-authorship network of co-authors of Alessio Amatu

This figure shows the co-authorship network connecting the top 25 collaborators of Alessio Amatu. A scholar is included among the top collaborators of Alessio Amatu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessio Amatu. Alessio Amatu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tosi, Federica, Gianluca Mauri, Erica Bonazzina, et al.. (2025). Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies. Drugs. 86(1). 37–57. 1 indexed citations

Patelli, Giorgio, Katia Bencardino, Alessio Amatu, et al.. (2024). Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 23(4). 295–308. 8 indexed citations

Negrão, Marcelo V., Philippe A. Cassier, Benjamin Solomon, et al.. (2023). MA06.03 KontRASt-01: Preliminary Safety and Efficacy of JDQ443 + TNO155 in Patients with Advanced, KRAS G12C-Mutated Solid Tumors. Journal of Thoracic Oncology. 18(11). S117–S118. 16 indexed citations

Patelli, Giorgio, Gianluca Mauri, Federica Tosi, et al.. (2023). Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer. Clinical Cancer Research. 29(22). 4530–4539. 23 indexed citations

Siena, Salvatore, Alessio Amatu, Katia Bencardino, et al.. (2023). Total neoadjuvant treatment without surgery for locally advanced rectal cancer: Prospective study to assess tumor response, circulating genetic, and epigenetic biomarkers, and stromal transcriptome to interpret clinical outcome (NO-CUT trial).. Journal of Clinical Oncology. 41(16_suppl). TPS3633–TPS3633. 2 indexed citations

Amatu, Alessio, Arianna Pani, Giorgio Patelli, et al.. (2021). Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment. European Journal of Cancer. 163. 16–25. 13 indexed citations

Patelli, Giorgio, Federica Tosi, Alessio Amatu, et al.. (2021). Strategies to tackle RAS-mutated metastatic colorectal cancer. ESMO Open. 6(3). 100156–100156. 50 indexed citations

Raimondi, Alessandra, Giovanni Fucà, Alberto Giovanni Leone, et al.. (2021). Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. ESMO Open. 6(5). 100246–100246. 10 indexed citations

Patelli, Giorgio, Federica Tosi, Gianluca Mauri, et al.. (2021). Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA. Targeted Oncology. 16(3). 309–324. 23 indexed citations

10.

Sartore‐Bianchi, Andrea, Federica Tosi, Francesca Bergamo, et al.. (2020). 507P Central nervous system recurrence in HER2-positive metastatic colorectal cancer. Annals of Oncology. 31. S455–S455. 2 indexed citations

11.

Mauri, Gianluca, Erica Bonazzina, Alessio Amatu, et al.. (2020). Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities. Cancer Treatment Reviews. 91. 102112–102112. 46 indexed citations

12.

Massihnia, Daniela, Elio Gregory Pizzutilo, Alessio Amatu, et al.. (2019). Liquid biopsy for rectal cancer: A systematic review. Cancer Treatment Reviews. 79. 101893–101893. 25 indexed citations

13.

Siravegna, Giulia, Andrea Sartore‐Bianchi, Benedetta Mussolin, et al.. (2017). Tracking aCAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor. Annals of Oncology. 28(6). 1302–1308. 31 indexed citations

14.

Amatu, Alessio, Andrea Sartore‐Bianchi, & Salvatore Siena. (2016). NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open. 1(2). e000023–e000023. 424 indexed citations breakdown →

15.

Sartore‐Bianchi, Andrea, Filippo Pietrantonio, Alessio Amatu, et al.. (2016). Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients. European Journal of Cancer. 71. 43–50. 19 indexed citations

16.

Cremolini, Chiara, Maria Di Bartolomeo, Alessio Amatu, et al.. (2015). BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis. Annals of Oncology. 26(10). 2092–2097. 118 indexed citations

17.

Ciardiello, Fortunato, Lisa Salvatore, Stefano Cascinu, et al.. (2015). Regorafenib for previously treated metastatic colorectal cancer (mCRC): results from 683 Italian patients treated in the open-label phase IIIB CONSIGN study. Annals of Oncology. 26. vi37–vi37. 3 indexed citations

18.

Amatu, Alessio, Andrea Sartore‐Bianchi, Cátia Moutinho, et al.. (2013). Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer. Clinical Cancer Research. 19(8). 2265–2272. 80 indexed citations

19.

Palumbo, Raffaella, Antônio Bernardo, Alberto Riccardi, et al.. (2011). Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. Clinical Breast Cancer. 12(1). 30–39. 11 indexed citations

20.

Poggi, Guido, Pietro Quaretti, Benedetta Montagna, et al.. (2010). Acute Thrombocytopenia: An Unusual Complication Occurring After Drug-Eluting Microspheres Transcatheter Hepatic Chemoembolization. CardioVascular and Interventional Radiology. 34(S2). 190–194. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact